Latest Headlines

  1. New Technologies For The Highly Parallel Optimization Of Cell Culture Processes
  2. Boehringer Ingelheim Invests More Than €200M To Establish Strategic Production Center For Veterinary Public Health In France

    Boehringer Ingelheim recently announced an investment of more than €200M into a new strategic production center for Veterinary Public Health.

  3. Thermo Fisher Continues To Expand Sterile Injectables Development Capabilities In Monza, Italy

    The sterile injectables market continues to grow quickly, driven in large part by the increase of biologic therapies in development. Recognizing the continued strong demand for sterile injectable development services, Thermo Fisher’s Pharma Services announced the $25 million investment in its Monza, Italy site to establish state-of-the-art development capabilities.

  4. Thermo Fisher Scientific Launches Quick To Clinic™ Program For Biologics

    Clients routinely have expressed the overwhelming need to get to the First-in-Human (Phase I) clinical trials as quickly as possible to generate safety for the IND submission. Several factors are behind this need, including discovery of much-needed innovative therapies, intense completion among developers in areas such as oncology, the need for small startups to reach the next milestone quickly in order to secure additional funding and more.

  5. Major Investments Expand Capacity And Services In Europe And Latin America

    Thermo Fisher Scientific is expanding its footprint in the European Union and Latin America to significantly increase capacity for cold and ambient clinical trial materials in support of complex clinical research .

  6. Centrexion Therapeutics Selects Skyland Analytics' Skyland PIMS Software As Their Data Repository For Manufacturing And Quality Compliance

    Skyland Analytics announced recently that Centrexion Therapeutics Corp. selected Skyland PIMS cloud-based software to streamline management of critical data in their process development and manufacturing operations.

  7. BPSA’s 8th Annual International Single-Use Summit To Focus On Innovation Strategies For Emerging And Existing Markets

    Innovation and commercialization of single-use technologies and issues impacting the supply chain will be the key focus of the Bio-Process Systems Alliance (BPSA) 8th Annual International Single-Use Summit, set for July 9-11, 2018, in Washington, D.C.

  8. Parker Bioscience Launches New System To Support Process And Product Protection

    Parker Bioscience has launched a new system which combines the fully automated bulk filtration and dispensing of biopharmaceutical products with a unique and validated shipping solution that ensures product integrity across the supply chain.

  9. Sartorius Stedim Biotech And Siemens Sign Long-Term Cooperation Agreement In The Area Of Automation

    The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation.

  10. WuXi Biologics To Invest $60M Into New Biologics Manufacturing Facility In Massachusetts

    WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it is to invest $60 million and hire approximately 150 employees to establish a state-of-the-art biologics clinical and commercial manufacturing facility in Worcester, Massachusetts in the United States.